# Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)

> **NCT00406783** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 547 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal
- Rhinitis, Allergic, Perennial

## Interventions

- **DRUG:** 5-mg Desloratadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00406783
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 547 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406783, "Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00406783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*